Joan J. Guinovart awarded with the Royal Academy of Pharmacy of Catalonia Prize Blog Post

Joan J. Guinovart was awarded XXII Prize from the Royal Academy of Pharmacy of Catalonia in recognition of his significant contribution to the field of pharmacy in Catalonia, as well as in Spain and the rest of the world. Guinovart served as the first director of the Institute for Research in Biomedicine (IRB Barcelona) and is the group leader of the Metabolic Engineering and Diabetes Therapy lab at the same institute based in PCB.

 

Defective glial cells can push neurons toward Parkinson’s disease Blog Post

Defective versions of human brain cells called astrocytes are linked to the buildup of a toxic protein that is one the hallmarks of Parkinson’s disease. This is one of the main conclusions of a study led by Antonella Consiglio, researcher at the Institute of Biomedicine of the University of Barcelona (IBUB) in the Barcelona Science Park, and the Bellvitge Biomedical Research Institute (IDIBELL), and Àngel Raya, from the Center of Regenerative Medicine in Barcelona (CMR[B]-IDIBELL).

 

Proteins can transfer electrons at a distance Blog Post

Researchers from the Institute for Bioengineering of Catalonia (IBEC) al PCB have published a study in Nature Communications that reveals that electron transfer can take place while a protein is approaching its partner site, and not only when the proteins are engaged, as was previously thought. The results open up a new way of thinking about how proteins interact, and can have implications in a better understanding of many processes – such as photosynthesis, respiration and detoxification – in which electron transfer plays an important role.

 

Iproteos, IBEC and VHIR to develop an innovative therapy against solid tumors Blog Post

The biotechnology company Iproteos and the Institute of Bioengineering of Catalonia (IBEC), based at the Barcelona Science Park (PCB), and the Vall d’Hebron Research Institute (VHIR) are set to develop an innovative treatment to slow down, stop and even reverse the growth of solid tumors, which represent more than 90% of cancer cases. The project, which received €935,000 from the Ministry of Science, Innovation and Universities, through of the call Retos Colaboración, will focus in its first phase on two of the most common solid tumors in children and adolescents, rhabdomyosarcoma and neuroblastoma, as well as in lung and colon cancer, which have the highest mortality rate in adults.

 

Whole Genix wins the 2018 Mediterráneo Excellente Prize for Medical Innovation Blog Post

The company Whole Genix, headquartered in the Barcelona Science Park, received the 2018 Mediterráneo Excelente Prize in the Medical Innovation category. This award was received during the gala marking the IV edition of these prizes, held on Friday in Hotel Arts in Barcelona. With these awards, the editorial group El Suplemento aims to assess and highlight entrepreneurial, scientific and cultural talent, as well as social and charity initiatives undertaken by companies, institutions and professionals from the Mediterranean Arc.

 

The Human Protein Atlas will pave the way to personalized medicine Blog Post

World leaders in proteomics are meeting with local doctors and researchers today and tomorrow at CosmoCaixa Barcelona, in an event held by B·Debate, an initiative by Biocat and Obra Social ‘la Caixa’, co-organized in this edition by the Barcelona Science Park (PCB), ProteoRed-ISCIII, Bellvitge Biomedical Research Institute (IDIBELL), Centre for Genomic Regulation (CRG) and Vall d’Hebron Institute of Oncology (VHIO). Four scientists of renowned prestige in this field –including Dr. Eliandre de Oliveira, head of the PCB’s Proteomics Platform– lead this debate.

 

IBEC and IRB Barcelona projects awarded funds from the 2017 edition of La Marató de TV3 Blog Post

Yesterday, La Fundació  Marató de TV3 announced the 36 projects awarded funding in the 2017 edition of the telethon, dedicated to infectious diseases. Among them is a project headed by Ernest Giralt, from the Institute for Research in Biomedicine (IRB Barcelona) and Jordi Vila, from the Barcelona Institute for Global Health (ISGlobal), and two projects led by Xavier Fernandez-Busquets and Antonio Juarez from the Institute for Bioengineering of Catalonia (IBEC).

 

The Structural Biology Unit at IBMB-CSIC received 400.000€ from “La Marató de TV3” 2017 edition Blog Post

F. Xavier Gomis Rüth and Núria Verdaguer, director and Scientific Director respectively of the Structural Biology Unit (SBU) at the Institut de Biologia Molecular de Barcelona (IBMB-CSIC) in the Barcelona Science Park, received the “La Marató” award for their projects on infectious diseases at a ceremony celebrated at the Academy of Medical and Health Sciences of Catalonia and the Balearic Islands.

 

Scientists from IBEC and UPC discover super-stretchy cells Blog Post

In a study published today in Nature, researchers from the Institute for Bioengineering of Catalonia (IBEC) at PCB and the Universitat Politècnica de Catalunya (UPC) report a new physical property of cells  that may explain the unusual ability of cells to undergo extreme deformations without breaking. The research could help us build better artificial organs or new bionic technologies such as organs-on-a-chip.

 

Cebiotex awarded the Cecot Recognition of Innovation prize 2018 Blog Post

Cebiotex– the first spin-off between the SJD Barcelona Children’s Hospital (HSJD) and the Universidad Politécnica de Catalunya (UPC)– awarded the Cecot Recognition of Innovation prize 2018. Joan Bertran, CEO and co-founder of the biotechnology company based at the Barcelona Science Park (Parc Científic de Barcelona, PCB), yesterday received the award at the Cecot Recognition of Business Progress prize-giving ceremony at the National Theatre of Catalonia, as part of the 24th Night of the Entrepreneur, which was chaired by the president of Catalonia, Quim Torra.